Cargando…
Tolvaptan Reduces Extracellular Fluid per Amount of Body Fluid Reduction Less Markedly than Conventional Diuretics
OBJECTIVE: Tolvaptan, a vasopressin V2 receptor antagonist, is a water diuretic, removing electrolyte-free water from the kidneys and affecting the water balance between the intracellular and extracellular fluid. We previously reported that tolvaptan efficiently reduced the intracellular fluid volum...
Autores principales: | Iwatani, Hirotsugu, Yamato, Masafumi, Bessho, Saki, Mori, Yuki, Notsu, Shoki, Asahina, Yuta, Koizumi, Shintaro, Kimura, Yoshiki, Shimomura, Akihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492492/ https://www.ncbi.nlm.nih.gov/pubmed/35110480 http://dx.doi.org/10.2169/internalmedicine.8533-21 |
Ejemplares similares
-
Tolvaptan Efficiently Reduces Intracellular Fluid: Working Toward a Potential Treatment Option for Cellular Edema
por: Kawabata, Hiroaki, et al.
Publicado: (2018) -
Diabetic nephropathy with marked extra-capillary cell proliferation: a case report
por: Morimoto, Madoka, et al.
Publicado: (2023) -
Tolvaptan: A Novel Diuretic in Heart Failure Management
por: Zulkifli Amin, Hilman, et al.
Publicado: (2016) -
Effects of Low-Dose Tolvaptan for Fluid Management After Cardiovascular Surgery
por: Matsuda, Yasuhiro, et al.
Publicado: (2022) -
Predictive factors for responders to tolvaptan in fluid management after cardiovascular surgery
por: Kido, Takashi, et al.
Publicado: (2016)